Determinants of long-term dual antiplatelet therapy use in post myocardial infarction patients: insights from the TIGRIS registry (2022)
- Authors:
- Autor USP: NICOLAU, JOSÉ CARLOS - FM
- Unidade: FM
- DOI: 10.1016/j.jjcc.2021.10.024
- Subjects: VASOS CORONÁRIOS; INFARTO DO MIOCÁRDIO; FÁRMACOS SINTÉTICOS
- Agências de fomento:
- Language: Inglês
- Imprenta:
- Source:
- Título: Journal of cardiology
- ISSN: 0914-5087
- Volume/Número/Paginação/Ano: v. 79, n. 4, p. 522-529, 2022
- Status:
- Nenhuma versão em acesso aberto identificada
-
ABNT
RUSSO, Juan J et al. Determinants of long-term dual antiplatelet therapy use in post myocardial infarction patients: insights from the TIGRIS registry. Journal of cardiology, v. 79, n. 4, p. 522-529, 2022Tradução . . Disponível em: https://doi.org/10.1016/j.jjcc.2021.10.024. Acesso em: 11 abr. 2026. -
APA
Russo, J. J., Yan, A. T., Pocock, S. J., Brieger, D., Owen, R., Sundell, K. A., et al. (2022). Determinants of long-term dual antiplatelet therapy use in post myocardial infarction patients: insights from the TIGRIS registry. Journal of cardiology, 79( 4), 522-529. doi:10.1016/j.jjcc.2021.10.024 -
NLM
Russo JJ, Yan AT, Pocock SJ, Brieger D, Owen R, Sundell KA, Bagai A, Granger CB, Cohen MG, Nicolau JC. Determinants of long-term dual antiplatelet therapy use in post myocardial infarction patients: insights from the TIGRIS registry [Internet]. Journal of cardiology. 2022 ; 79( 4): 522-529.[citado 2026 abr. 11 ] Available from: https://doi.org/10.1016/j.jjcc.2021.10.024 -
Vancouver
Russo JJ, Yan AT, Pocock SJ, Brieger D, Owen R, Sundell KA, Bagai A, Granger CB, Cohen MG, Nicolau JC. Determinants of long-term dual antiplatelet therapy use in post myocardial infarction patients: insights from the TIGRIS registry [Internet]. Journal of cardiology. 2022 ; 79( 4): 522-529.[citado 2026 abr. 11 ] Available from: https://doi.org/10.1016/j.jjcc.2021.10.024 - Sex difference in patients with ischemic heart failure undergoing surgical revascularization results from the STICH trial (Surgical Treatment for Ischemic Heart Failure)
- Activated Clotting Time to Guide Heparin Dosing in Non-ST-Segment-Elevation Acute Coronary Syndrome Patients Undergoing Percutaneous Coronary Intervention and Treated With IIb/IIIa Inhibitors Impact on Ischemic and Bleeding Outcomes: Insights From the TAO Trial
- Patterns of Long-term Thienopyridine Therapy and Outcomes in Patients With Acute Coronary Syndrome Treated With Coronary Stenting: Observations From the TIMI-38 Coronary Stent Registry
- Anticoagulation With Otamixaban and Ischemic Events in Non–ST-Segment Elevation Acute Coronary Syndromes: The TAO Randomized Clinical Trial
- Aneurisma Verdadeiro Gigante e Calcificado do Ventrículo Esquerdo: como Proceder?
- Effect of dapagliflozin on outpatient worsening of patients with heart failure and reduced ejection fraction a prespecified analysis of DAPA-HF
- Benefit of Adding Ezetimibe to Statin Therapy on Cardiovascular Outcomes and Safety in Patients With Versus Without Diabetes Mellitus Results From IMPROVE-IT (Improved Reduction of Outcomes: Vytorin Efficacy International Trial)
- Comparison between two different local hemostatic methods for dental extractions in patients on dual antiplatelet therapy: a within-person, single-blind, randomized study
- Randomized, placebo-controlled phase 2b study to evaluate the safety and efficacy of recombinant human lecithin cholesterol acyltransferase in acute ST-segment-elevation myocardial infarction: results of REAL-TIMI 63B
- Predictors of subclinical carotid atherosclerosis in middle-aged women
Informações sobre a disponibilidade de versões do artigo em acesso aberto coletadas automaticamente via oaDOI API (Unpaywall).
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
